~7 spots leftby Oct 2025

Mobile Health App for High Blood Pressure

Recruiting in Palo Alto (17 mi)
DG
Overseen byDavid G. Beiser, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: University of Chicago
Disqualifiers: Pregnancy, Opioid dependency, Homelessness, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to test the proof-of-concept for adding a novel mHealth application, USeeBP, to the established UChicago Medicine Ambulatory Medicine Remote-Patient Monitoring (UCM-RPM) Hypertension Management Program in a population of African American adults with poorly controlled hypertension.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment, but it's best to confirm with the study team.

What data supports the effectiveness of the treatment USeeBP for high blood pressure?

Research shows that mobile health apps can help people manage high blood pressure by improving medication adherence and encouraging lifestyle changes. Apps that combine blood pressure monitoring with feedback and education have been shown to help reduce blood pressure and improve how well people stick to their treatment plans.12345

Is the Mobile Health App for High Blood Pressure safe for humans?

The research does not specifically mention safety concerns for the mobile health app, but it shows that older adults engaged well with the app for blood pressure monitoring, suggesting it is generally safe to use.35678

How does the mobile health app treatment for high blood pressure differ from other treatments?

This mobile health app treatment is unique because it uses smartphone technology to help patients monitor their blood pressure at home, potentially improving medication adherence and lifestyle changes. Unlike traditional treatments, it offers a convenient way to track and manage blood pressure through self-measurement and digital engagement, which may be particularly appealing to younger users.135910

Research Team

DG

David G. Beiser, MD

Principal Investigator

University of Chicago

Eligibility Criteria

This trial is for African American adults aged 18-65 with high blood pressure (SBP ≥ 160 mmHg). Participants must have access to an iPhone, Wi-Fi or data plan, and be able to use the USeeBP app and a wireless blood pressure cuff. They should not be homeless, recently hospitalized for psychiatric reasons, pregnant, prisoners, opioid-dependent or have certain severe medical conditions.

Inclusion Criteria

Person of African descent
You are currently enrolled or eligible to participate in the UCM-RPM Hypertension Management Program.
You have an Apple iPhone that can work with the Apple Health app.
See 10 more

Exclusion Criteria

Your blood pressure is higher than 180/110 before starting the study.
Prior enrollment in the study
You are currently dependent on opioids.
See 7 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the USeeBP mHealth app alongside the UCM-RPM program to monitor and manage blood pressure

12 weeks
Regular virtual check-ins via app and EPIC MyChart

Follow-up

Participants are monitored for changes in blood pressure control and medication adherence

4 weeks

Treatment Details

Interventions

  • USeeBP (Behavioural Intervention)
Trial OverviewThe study tests a mobile health application called USeeBP as part of the UChicago Medicine Remote-Patient Monitoring Hypertension Management Program. It aims to see if this app can help improve blood pressure control in African Americans with unmanaged hypertension.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: USeeBPExperimental Treatment1 Intervention
Participants will be asked to use the USeeBP mHealth app alongside participating in UCM-RPM program as part of their routine care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1,086
Recruited
844,000+
Pete Salzmann profile image

Pete Salzmann

University of Chicago

Chief Executive Officer since 2018

MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business

Anh Nguyen profile image

Anh Nguyen

University of Chicago

Chief Medical Officer

MD from Rutgers New Jersey Medical School, MBA from University of Chicago

Findings from Research

A randomized clinical trial involving 2101 participants found that enhanced self-measured blood pressure (SMBP) using a smartphone application did not significantly reduce blood pressure more than standard SMBP methods over 6 months.
Both enhanced and standard SMBP methods showed similar levels of patient satisfaction, with around 70% of participants likely to recommend their devices, indicating that the added technology did not improve outcomes.
Effectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application: A Randomized Clinical Trial.Pletcher, MJ., Fontil, V., Modrow, MF., et al.[2023]
The SMART-BP trial is evaluating the effectiveness of a mobile app (SMBP-App) that provides tailored recommendations for blood pressure management compared to standard self-monitoring of blood pressure (SMBP) in 180 patients with hypertension over a 24-week period.
The primary goal is to determine if the SMBP-App can lead to greater reductions in mean home systolic blood pressure and improve medication adherence compared to SMBP alone.
Self-Monitoring of Blood Pressure and Feed-back Using APP in TReatment of UnconTrolled Hypertension (SMART-BP): A Randomized Clinical Trial.Choi, DJ., Park, JJ., Yoon, M., et al.[2023]
A review of 151 high blood pressure apps revealed that most only offer basic features like blood pressure monitoring, lifestyle advice, and information about hypertension, indicating a lack of comprehensive self-management support.
The presence of social support features was weakly correlated with download frequency, suggesting that users may value community engagement, while apps tailored for specific BP monitors received higher ratings, highlighting the importance of compatibility in user satisfaction.
Apps to Support Self-Management for People With Hypertension: Content Analysis.Hui, CY., Creamer, E., Pinnock, H., et al.[2020]

References

Effectiveness of Standard vs Enhanced Self-measurement of Blood Pressure Paired With a Connected Smartphone Application: A Randomized Clinical Trial. [2023]
Self-Monitoring of Blood Pressure and Feed-back Using APP in TReatment of UnconTrolled Hypertension (SMART-BP): A Randomized Clinical Trial. [2023]
Apps to Support Self-Management for People With Hypertension: Content Analysis. [2020]
Effect of Home Blood Pressure Monitoring via a Smartphone Hypertension Coaching Application or Tracking Application on Adults With Uncontrolled Hypertension: A Randomized Clinical Trial. [2020]
[Mobile applications and management of hypertension: possibilities, problems and perspectives]. [2021]
Randomized feasibility trial of a digital intervention for hypertension self-management. [2023]
Quality of Blood Pressure Tracking Apps for the iPhone: Content Analysis and Evaluation of Adherence With Home Blood Pressure Measurement Best Practices. [2020]
SMS-facilitated home blood pressure monitoring: A qualitative analysis of resultant health behavior change. [2020]
The Potential of mHealth Applications in Improving Resistant Hypertension Self-Assessment, Treatment and Control. [2020]
Engagement in Self-measured Blood Pressure Monitoring Among Medically Underresourced Participants (the Reach Out Trial): Digital Framework Qualitative Study. [2023]